Adding HIV Risk Reduction Strategies to Drug Abuse Treatment Has Favorable Outcomes for Pregnant Women at Risk of Infection

2007 ◽  
Keyword(s):  
At Risk ◽  
Drug Abuse ◽  
Pregnant Women ◽  
Risk Reduction ◽  
Hiv Risk ◽  
Drug Abuse Treatment ◽  
Risk Of Infection ◽  
Reduction Strategies ◽  
Abuse Treatment ◽  
Risk Reduction Strategies

Psychiatric status and HIV risk reduction among residential drug abuse treatment clients

Addiction ◽  
1995 ◽  
Vol 90 (10) ◽  
pp. 1377-1387 ◽  
Author(s):  
JANE McCUSKER ◽  
RISE GOLDSTEIN ◽  
CAROL BIGELOW ◽  
MARTHA ZORN
Keyword(s):  
Drug Abuse ◽  
Risk Reduction ◽  
Hiv Risk ◽  
Drug Abuse Treatment ◽  
Hiv Risk Reduction ◽  
Psychiatric Status ◽  
Abuse Treatment

Psychiatric status and HIV risk reduction among residential drug abuse treatment clients

Addiction ◽  
2006 ◽  
Vol 90 (10) ◽  
pp. 1377-1387 ◽  
Author(s):  
JANE McCUSKER ◽  
RISË GOLDSTEIN ◽  
CAROL BIGELOW ◽  
MARTHA ZORN
Keyword(s):  
Drug Abuse ◽  
Risk Reduction ◽  
Hiv Risk ◽  
Drug Abuse Treatment ◽  
Hiv Risk Reduction ◽  
Psychiatric Status ◽  
Abuse Treatment

scholarly journals Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups

2016 ◽  
Vol 20 (9) ◽  
pp. 1893-1906
Author(s):  
Lauren Gooden ◽  
Lisa R. Metsch ◽  
Margaret R. Pereyra ◽  
C. Kevin Malotte ◽  
Louise F. Haynes ◽  
...  
Keyword(s):  
Drug Abuse ◽  
Risk Reduction ◽  
Sexual Risk ◽  
Risk Behaviors ◽  
Hiv Risk ◽  
National Sample ◽  
Drug Abuse Treatment ◽  
Hiv Risk Reduction ◽  
Risk Reduction Counseling ◽  
Abuse Treatment

HIV Risk Reduction Strategies Scale

1996 ◽  
Author(s):  
Kalichman Seth C. ◽  
Rompa David ◽  
Brenda Coley
Keyword(s):  
Risk Reduction ◽  
Hiv Risk ◽  
Hiv Risk Reduction ◽  
Reduction Strategies ◽  
Risk Reduction Strategies

scholarly journals Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema

2021 ◽  
Vol 28 (1) ◽  
pp. 455-470
Author(s):  
Shirin M. Shallwani ◽  
Anna Towers ◽  
Anne Newman ◽  
Shannon Salvador ◽  
Angela Yung ◽  
...  
Keyword(s):  
At Risk ◽  
Risk Reduction ◽  
Controlled Trial ◽  
Gynecological Cancer ◽  
Intervention Group ◽  
Future Research ◽  
Control Group ◽  
Randomized Controlled ◽  
Reduction Strategies ◽  
Risk Reduction Strategies

There is limited knowledge on non-invasive lymphedema risk-reduction strategies for women with gynecological cancer. Understanding factors influencing the feasibility of randomized controlled trials (RCTs) can guide future research. Our objectives are to report on the design and feasibility of a pilot RCT examining a tailored multidimensional intervention in women treated for gynecological cancer at risk of lymphedema and to explore the preliminary effectiveness of the intervention on lymphedema incidence at 12 months. In this pilot single-blinded, parallel-group, multi-centre RCT, women with newly diagnosed gynecological cancer were randomized to receive post-operative compression stockings and individualized exercise education (intervention group: IG) or education on lymphedema risk-reduction alone (control group: CG). Rates of recruitment, retention and assessment completion were recorded. Intervention safety and feasibility were tracked by monitoring adverse events and adherence. Clinical outcomes were evaluated over 12 months: presence of lymphedema, circumferential and volume measures, body composition and quality of life. Fifty-one women were recruited and 36 received the assigned intervention. Rates of recruitment and 12-month retention were 47% and 78%, respectively. Two participants experienced post-operative cellulitis, prior to intervention delivery. At three and six months post-operatively, 67% and 63% of the IG used compression ≥42 h/week, while 56% engaged in ≥150 weekly minutes of moderate-vigorous exercise. The cumulative incidence of lymphedema at 12 months was 31% in the CG and 31.9% in the IG (p = 0.88). In affected participants, lymphedema developed after a median time of 3.2 months (range, 2.7–5.9) in the CG vs. 8.8 months (range, 2.9–11.8) in the IG. Conducting research trials exploring lymphedema risk-reduction strategies in gynecological cancer is feasible but challenging. A tailored intervention of compression and exercise is safe and feasible in this population and may delay the onset of lymphedema. Further research is warranted to establish the role of these strategies in reducing the risk of lymphedema for the gynecological cancer population.

scholarly journals The effects of planned duration of residential drug abuse treatment on recovery and HIV risk behavior.

1997 ◽  
Vol 87 (10) ◽  
pp. 1637-1644 ◽  
Author(s):  
J McCusker ◽  
C Bigelow ◽  
R Frost ◽  
F Garfield ◽  
R Hindin ◽  
...  
Keyword(s):  
Drug Abuse ◽  
Risk Behavior ◽  
Hiv Risk ◽  
Hiv Risk Behavior ◽  
Drug Abuse Treatment ◽  
Abuse Treatment
Sign in / Sign up

Export Citation Format

Share Document